Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial - Paz-Ares, L; Dvorkin, M; Chen, Y (Lancet, 2019)
et al.